Skip to content

Evaluation of the safety and efficacy of electronic image processor in detecting nasal, pharyngeal and larynx with electronic nasopharyngeal endoscopy - prospective, multicenter, randomized parallel

Evaluation of the safety and efficacy of electronic image processor in detecting nasal, pharyngeal and larynx with electronic nasopharyngeal endoscopy - prospective, multicenter, randomized parallel

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013877
Enrollment
Unknown
Registered
2017-12-12
Start date
2018-02-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal, pharynx, throat to check

Interventions

Control group:Electronic nasopharyngoscope
Test group:Electronic nasopharyngeal endoscope

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: The subjects were not allowed to enter the study if either of articles 1 and 3 answered no, or article 4, paragraph 8, answered No. 1. Between the ages of 18 and 72 (including 18 and 72 years of age), male and female; 2. no obvious language, hearing and communication barriers, no obvious intelligence, mental retardation; 3. Subjects fully understand the benefits and risks of this trial, willing to participate in and sign the informed consent form; 4. Patients with nasal symptoms, such as nasal obstruction, rhinorrhea, olfactory dysfunction, nasal headache, enlarged neck lymph nodes; 5. patients with symptoms of pharyngeal diseases, such as oropharyngeal, laryngopharyngeal sore throat, burning sensation, abnormal pharynx, swallowing difficulties, snoring, etc.; 6. Patients with symptoms of throat disease, such as hoarseness, sore throat, swallowing difficulties, etc .; 7. perioperative examination of throat diseases; 8. Occupational use throat routine examination.

Exclusion criteria

Exclusion criteria: 1. acute severe nasopharyngeal diseases; 2. acute bleeding; 3. uncontrolled asthmatic or unstable asthma; 4. Respiratory failure; 5. past anesthesia allergy; 6. Patients with severe cardiopulmonary disease (eg severe arrhythmia, ventricular rate was slow (ventricular rate 1.5 times upper limit of normal), sepsis And other unsuitable; 7. severe liver and kidney disease patients (liver and kidney function each with two or more indicators> 2 times the upper limit of normal); 8. Family Planning, Breastfeeding and Pregnancy Women within 3 Months; 9. 3 months to participate in other clinical trials; 10. Other researchers think it is not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Excellent rate of image quality;

Countries

China

Contacts

Public ContactHaibo Shi

Shanghai Sixth People's Hospital

haibo99@hotmail.com+86 18930177657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026